Chemoinformaics analysis of TRANS-N-METHYL-4-METHOXYPROLINE
| Molecular Weight | 159.185 | nRot | 2 |
| Heavy Atom Molecular Weight | 146.081 | nRig | 6 |
| Exact Molecular Weight | 159.09 | nRing | 1 |
| Solubility: LogS | 0.166 | nHRing | 1 |
| Solubility: LogP | -1.879 | No. of Aliphatic Rings | 1 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 24 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 13 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 7 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 23.8643 |
| nHD | 1 | BPOL | 17.3557 |
| QED | 0.605 |
| Synth | 3.205 |
| Natural Product Likeliness | 0.554 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.029 |
| HIA | 0.216 |
| CACO-2 | -5.584 |
| MDCK | 0.00184535 |
| BBB | 0.621 |
| PPB | 0.0870008 |
| VDSS | 0.584 |
| FU | 0.971097 |
| CYP1A2-inh | 0.01 |
| CYP1A2-sub | 0.089 |
| CYP2c19-inh | 0.015 |
| CYP2c19-sub | 0.583 |
| CYP2c9-inh | 0.007 |
| CYP2c9-sub | 0.473 |
| CYP2d6-inh | 0.01 |
| CYP2d6-sub | 0.356 |
| CYP3a4-inh | 0.004 |
| CYP3a4-sub | 0.08 |
| CL | 8.336 |
| T12 | 0.777 |
| hERG | 0.018 |
| Ames | 0.01 |
| ROA | 0.023 |
| SkinSen | 0.207 |
| Carcinogencity | 0.126 |
| EI | 0.259 |
| Respiratory | 0.154 |
| NR-Aromatase | 0.002 |
| Antiviral | No |
| Prediction | 0.945017 |